Clinical trial
Evaluation of the Effect of Good Pain Management (GPM) Ward Program on Pattern of Care and Patient-Reported Outcomes of Moderate to Severe Cancer Pain Patients
NCT03155516 is registered in ClinicalTrials.gov with Taiwan Mundipharma Pharmaceuticals Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of Good Pain Management (GPM) Ward Program on Pattern of Care and Patient-Reported Outcomes of Moderate to Severe Cancer Pain Patients
- Lead sponsor
- Taiwan Mundipharma Pharmaceuticals Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 30, 2016
- Completion date
- August 29, 2019
- Enrollment
- 150 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, pain